Drug Trial Radar · NCT05619926
Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor
Last checked: Nov 19, 2026Latest source record: Jan 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Jan 9, 2023
Primary completion
Aug 25, 2023
Study completion Aug 25, 2023
Sponsor
- Lead sponsor
- Staidson (Beijing) Biopharmaceuticals Co., LtdIndustry
- Sponsor type
- Industry
- Collaborators
- Beijing Novikang Medical Technology Co., LTD
- First posted
- Nov 17, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the safety,efficacy,pharmacokinetics and pharmacodynamics of multiple-dose of STSP-0601 at two dose levels for the treatment of bleeding episodes in hemophilia A or B patients without inhibitor.
Conditions
- Hemophilia
Interventions
STSP-0601 for InjectionDrug
Intravenous Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of adverse eventsTime frame: From day 0 to up to day 4
- Proportion of successfully treated bleeding episodesTime frame: 8 hours after first administration of study drug
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Lanzhou University First Hospita
Lanzhou, Gansu, China
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
North China University of Technology Affiliated Hospital
Tangshan, Hebei, China
The First Affiliated Hospital of Nanyang Medical College
Nanyang, Henan, China
Henan Cancer Hospital
Zhengzhou, Henan, China
Xiangya Hospital of Central South University
Changsha, Hunan, China
Nanjing Gulou Hospital
Nanjing, Jiangsu, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Xi'an Central Hospital
Xi’an, Shanxi, China
Hospital of Hematology, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China
The Second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.